Venetoclax and azacitidine therapy in acute myeloid leukemia patients with severe renal impairment.
Naka R, Kondo T, Nishikubo M, Muranushi H, Ueda Y, Oka T, Wada F, Kanda J, Yamamoto S, Watanabe M, Okada S, Imada K, Nakabo Y, Mizutani Y, Nannya Y, Ogawa S, Ishikawa T.
Naka R, et al. Among authors: ishikawa t.
Am J Hematol. 2023 Sep;98(9):E251-E254. doi: 10.1002/ajh.27012. Epub 2023 Jun 28.
Am J Hematol. 2023.
PMID: 37381699
Free article.
No abstract available.